The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes von Younossi, Zobair, Aggarwal, Priya, Shrestha, Ichhya, Fernandes, João, Johansen, Pierre, Augusto, Margarida, Nair, Sunita

Volltext

Validation of the IHE Cohort Model of Type 2 Diabetes and the impact of choice of macrovascular risk equations von Lundqvist, Adam, Steen Carlsson, Katarina, Johansen, Pierre, Andersson, Emelie, Willis, Michael

Volltext

A population‐adjusted indirect comparison of cardiovascular benefits of once‐weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with... von Evans, Lyndon Marc, Mellbin, Linda, Johansen, Pierre, Lawson, Jack, Paine, Abby, Sandberg, Anna

Volltext

The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies von Tapper, Elliot B., Fleming, Charlotte, Rendon, Adriana, Fernandes, João, Johansen, Pierre, Augusto, Margarida, Nair, Sunita

Volltext

Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Econ... von Willis, Michael, Fridhammar, Adam, Gundgaard, Jens, Nilsson, Andreas, Johansen, Pierre

Volltext

Incorporating Cardioprotective Effects of Once-Weekly Semaglutide in Estimates of Health Benefits for Patients with Type 2 Diabetes von EVANS, MARC, JOHANSEN, PIERRE, VRAZIC, HRVOJE

Volltext

The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review von Witkowski, Michal, Moreno, Søren Ilsøe, Fernandes, João, Johansen, Pierre, Augusto, Margarida, Nair, Sunita

Volltext

A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release, Dulaglutide and Liraglutide in the UK von Johansen, Pierre, Sandberg, Anna, Capehorn, Matthew

Volltext

Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM) von Willis, Michael, Johansen, Pierre, Nilsson, Andreas, Asseburg, Christian

Volltext

FRI-201 Health care resource utilization for patients diagnosed and at high risk of metabolic dysfunction-associated steatohepatitis in Stockholm, Sweden-a REVEAL-MASH study von Grip, Emilie Toresson, Apecechea, Nikolas Scheffer, Basuroy, Ron, Johansen, Pierre, Mangla, Kamal Kant, Skröder, Helena, Hagstrom, Hannes

Volltext

OS-052 Characteristics and risk of major adverse liver outcomes and major cardiovascular events among swedish patients with diagnosed and high risk of metabolic dysfunction-associa... von Grip, Emilie Toresson, Apecechea, Nikolas Scheffer, Basuroy, Ron, Johansen, Pierre, Mangla, Kamal Kant, Skröder, Helena, Hagström, Hannes

Volltext

Evaluation of the long‐term cost‐effectiveness of once‐weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK von Viljoen, Adie, Hoxer, Christina S., Johansen, Pierre, Malkin, Samuel, Hunt, Barnaby, Bain, Stephen C.

Volltext

External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions von Lopes, Sandra, Johansen, Pierre, Lamotte, Mark, McEwan, Phil, Olivieri, Anamaria-Vera, Foos, Volker

Volltext

Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements von Johansen, Pierre, Howard, Daniel, Bishop, Ryan, Moreno, Søren Ilsøe, Buchholtz, Kristine

Volltext

Efficacy of Once-Weekly Semaglutide vs Empagliflozin Added to Metformin in Type 2 Diabetes: Patient-Level Meta-analysis von Lingvay, Ildiko, Capehorn, Matthew S, Catarig, Andrei-Mircea, Johansen, Pierre, Lawson, Jack, Sandberg, Anna, Shaw, Robert, Paine, Abby

Volltext

Authors’ reply to Comment on “External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions” von Lopes, Sandra, Johansen, Pierre, Lamotte, Mark, McEwan, Phil, Olivieri, Anamaria-Vera, Foos, Volker

Volltext

Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden von Persson, Sofie, Johansen, Pierre, Andersson, Emelie, Lindgren, Peter, Thielke, Desirée, Thorsted, Brian L., Jendle, Johan, Steen Carlsson, Katarina

Volltext

Cost-Effectiveness of Once-Weekly Semaglutide 1.0 mg vs. Dulaglutide 1.5 mg as Add-On to Metformin in the Treatment of Type 2 Diabetes in Canada von JOHANSEN, PIERRE, HÅKAN-BLOCH, JONAS, LIU, AIDEN R., PERSSON, SOFIE, GRIP, EMILIE TORESSON

Volltext

The Effect of Bariatric Surgery on Healthcare Costs and Labor Market Attachment von Bøgelund, Mette, Jørgensen, Nils B., Madsbad, Sten, Spanggaard, Maria, Panton, Ulrik H., Pedersen, Mikkel H., Johansen, Pierre

Volltext

Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20years of linked national registry data in Sweden von Persson, Sofie, Johansen, Pierre, Andersson, Emelie, Lindgren, Peter, Thielke, Desirée, Thorsted, Brian L, Jendle, Johan, Katarina Steen Carlsson

Volltext